The HER Act establishes federal and state grant programs to research the impact of endocrine-disrupting chemicals in women's personal care products and to fund public awareness campaigns.
Shontel Brown
Representative
OH-11
The Health and Endocrine Research on personal care products for women Act (HER Act) establishes grant programs to fund research into the effects of endocrine-disrupting chemicals (EDCs) in personal care products on women's reproductive health. These grants will support scientific investigation, state-level awareness campaigns about safer alternatives, and provide recommendations to Congress for strengthening FDA regulation of harmful chemicals. The bill mandates regular reporting on research findings and the impact of state initiatives.
The newly introduced Health and Endocrine Research on personal care products for women Act, mercifully shortened to the HER Act, is all about figuring out what’s actually in the stuff we use daily—and what those ingredients are doing to us. Specifically, this bill sets up federal grant programs, managed by the Secretary of Health and Human Services (HHS), to fund serious scientific research into how endocrine-disrupting chemicals (EDCs) in personal care products affect women’s reproductive health. Think of EDCs as chemical imposters that can mimic or block your body’s natural hormones—and ‘personal care products’ are defined here as anything from shampoo to lotion that counts as a cosmetic under federal law.
This isn't just a vague call for research; the bill mandates specific studies. Grants, administered through the National Institute of Environmental Health Sciences (NIEHS), must focus on the link between EDCs in cosmetics and female reproductive toxicity. If you’re a woman or have a woman in your life, this is about getting hard data on how the chemicals in everyday products might be messing with fertility, pregnancy, and other health outcomes. The goal is to move beyond speculation and establish clear scientific links, which is crucial for making informed health decisions.
The HER Act also recognizes that health impacts aren't uniform across the country. It allocates funds directly to states—including territories and tribal organizations—to conduct local investigations into the impact of EDCs in personal care products on women’s health. On top of that, these state grants must fund public awareness campaigns. This means your local health department could soon be running programs to educate the community about alternative, lower-risk products. For busy parents trying to make safer choices at the drugstore, this could be a huge help, offering localized, reliable information instead of relying on internet rumors.
Here’s where the rubber meets the road for future regulation. Every five years, starting five years after the bill becomes law, the HHS Secretary has to deliver a detailed report to Congress and the public. This report must summarize the research findings, highlight any disparities in access to safer products, and, crucially, list which personal care products the Secretary deems safe or harmful based on the evidence. Most importantly, the report must suggest evidence-based strategies to give the Food and Drug Administration (FDA) more power to regulate EDCs in these products when they pose a risk to women’s reproductive health. This five-year cycle is a bit of a mixed bag: it gives researchers plenty of time to gather solid data, but five years can feel like a long time to wait for action if the research uncovers serious, immediate concerns. However, it sets a clear mechanism for pushing for stronger federal oversight, which is currently quite limited in the cosmetics industry. For manufacturers, this serves as a clear notice: once the science is in, regulatory changes are likely coming down the pipeline.